홈 > 시장보고서 > 의료기기

시장보고서

상품코드

1641762

세계의 온열요법 기기 시장 : 제품별, 용도별, 최종사용자별 - 기회 분석과 산업 예측(2024-2033년)

Hyperthermia Devices Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

발행일: 2024년 12월 | 리서치사:

Allied Market Research | 페이지 정보: 영문 290 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

온열요법 기기 시장은 2023년에 1억 6,820만 달러로 2024년부터 2033년까지 연평균 5.6%의 CAGR로 성장하여 2033년에는 2억 9,010만 달러에 달할 것으로 예상됩니다.

온열요법 기기는 치료 목적으로 체내 조직의 온도를 높이는 데 사용되는 의료기기로, 암의 보조 치료로 사용되는 경우가 많습니다. 신체의 특정 부위에 조절된 열을 가함으로써 혈류를 개선하고 치료에 대한 암세포의 민감도를 높여 화학요법이나 방사선 치료 등의 치료 효과를 높입니다.

온열요법 기기 세계 시장 성장의 배경에는 전 세계 암 환자 증가로 인해 화학요법이나 방사선 치료와 같은 기존 암 치료의 효과를 향상시키는 온열요법 기기를 포함한 혁신적인 치료법에 대한 수요가 증가하고 있는 것이 있습니다. 세계보건기구(WHO)가 발표한 2022년 조사에 따르면, 암은 전 세계 주요 사망 원인으로 2020년에는 약 1,000만 명이 사망할 것으로 예상됩니다. 따라서 보다 덜 침습적인 암 치료를 원하는 환자가 증가함에 따라, 온열요법 기기는 기존 접근 방식에 비해 부작용을 최소화하면서 국소 조직을 타겟팅할 수 있어 인기를 얻고 있습니다. 또한, 치료 성적 향상과 부작용 감소에 대한 역할 등 온열요법의 장점에 대한 인식이 높아짐에 따라 임상 현장에서의 수용이 확대되고 있습니다. 또한, 치료 결과 개선 및 부작용 감소에 대한 역할 등 온열요법의 장점에 대한 인식이 높아지면서 임상에서 온열요법의 수용이 확대되고 있으며, 이는 시장 성장을 촉진하고 있습니다. 또한, 노인 인구의 급격한 증가는 세계 시장의 주요 원동력이 되고 있습니다. 이는 노화가 비정상 세포 및 암세포에 대한 감시 기능 저하와 같은 면역 체계의 효율성 저하와 관련이 있다는 사실에 기인합니다. 이 때문에 온열요법 기기를 포함한 첨단 치료 옵션에 대한 수요가 크게 증가하고 있습니다. 세계보건기구(WHO)가 발표한 2024년 조사에 따르면, 노인 인구가 2020년 10억 명에서 2030년까지 14억 명으로 증가할 것으로 예상됩니다. 또한 80세 이상 노인의 수는 2050년까지 4억 2,600만 명에 달할 것으로 추정됩니다. 전 세계적으로 종양 전문 클리닉과 병원이 증가함에 따라 환자의 예후를 개선하기 위해 고주파온열치료와 같은 첨단 암 치료법의 채택이 더욱 촉진되고 있습니다. 이러한 장점에도 불구하고, 온열요법은 그 효과와 암 치료 프로토콜에의 통합에 대한 의료진의 인식과 교육이 제한적이기 때문에 아직 충분히 활용되지 못하고 있습니다. 특히 중저소득 지역에서는 장비 및 관련 시술을 포함한 온열요법 치료의 비용이 많은 환자와 의료 시스템에서 감당할 수 없는 수준이어서 시장 성장을 더욱 억제하고 있습니다. 반면, 개선된 온열 전달 시스템, 실시간 온도 모니터링, 비침습적 장치와 같은 기술 혁신은 온열 치료의 안전성, 정확성, 유효성을 향상시키고 있습니다. 이러한 개발은 예측 기간 동안 세계 시장 확대에 유익한 기회를 제공할 것으로 예상됩니다.

온열요법 기기 세계 시장 분석은 제품, 용도, 최종사용자, 지역으로 구분됩니다. 제품 기준으로 시장은 마이크로파 온열요법 기기와 초음파 온열요법 기기로 분류됩니다. 용도별로는 유방암, 전립선암, 자궁경부암, 기타로 분류됩니다. 최종사용자에 따라 병원, 암 치료 센터, 기타로 세분화됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

주요 조사 결과

제품별로는 초음파 온열요법 기기 분야가 2024년부터 2033년까지 시장을 독점할 것으로 예측됩니다.

용도별로는 전립선암 분야가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

최종사용자별로는 병원 부문이 예측 기간 동안 눈에 띄는 속도로 성장할 것으로 예상됩니다.

지역별로는 북미가 2023년 매출 기준으로 가장 큰 시장 점유율을 차지했으며, 예측 기간 동안에도 시장을 장악할 가능성이 높습니다.

세계 온열요법 기기 시장에서 사업을 전개하고 있는 주요 기업으로는 Pyrexar Medical, Oncotherm, Celsius42, Andromedic, Pearson, Nanjing Greathope, Shanghai Huayuan, MagForce AG, Nanopores, Sensius 등이 있습니다. 이들 주요 기업들은 경쟁 시장에서 발판을 마련하기 위해 사업 확장, 신제품 출시, 제휴 등 다양한 주요 개발 전략을 채택하고 있습니다.

본 보고서에서 가능한 커스터마이징(추가 비용과 일정이 있습니다. )

국가, 지역, 세계 수준의 환자/역학 데이터
규제 가이드라인
고객의 관심사에 따른 추가 기업 프로파일
국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
기업 개요 확장 목록
과거 시장 데이터
SWOT 분석

시장 개요
북미
- 주요 시장 동향과 기회
- 미국의 온열요법 기기 시장
- 캐나다의 온열요법 기기 시장
- 멕시코의 온열요법 기기 시장
유럽
- 주요 시장 동향과 기회
- 프랑스의 온열요법 기기 시장
- 독일의 온열요법 기기 시장
- 이탈리아의 온열요법 기기 시장
- 스페인의 온열요법 기기 시장
- 영국의 온열요법 기기 시장
- 기타 유럽의 온열요법 기기 시장
아시아태평양
- 주요 시장 동향과 기회
- 중국의 온열요법 기기 시장
- 일본의 온열요법 기기 시장
- 인도의 온열요법 기기 시장
- 한국의 온열요법 기기 시장
- 호주의 온열요법 기기 시장
- 기타 아시아태평양의 온열요법 기기 시장
라틴아메리카, 중동 및 아프리카
- 주요 시장 동향과 기회
- 브라질의 온열요법 기기 시장
- 남아프리카공화국의 온열요법 기기 시장
- 사우디아라비아의 온열요법 기기 시장
- 기타 라틴아메리카, 중동 및 아프리카의 온열요법 기기 시장

제8장 경쟁 구도

소개
주요 성공 전략
주요 10개 기업 제품 매핑
경쟁 대시보드
경쟁 히트맵
주요 기업의 포지셔닝, 2023년

제9장 기업 개요

Pyrexar Medical
Oncotherm
Celsius42
Andromedic
Pearson
Nanjing Greathope
Shanghai Huayuan
MagForce AG
Nanopores
Sensius

ksm 25.02.20

The hyperthermia devices market was valued at $168.2 million in 2023, and is projected to reach $290.1 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Hyperthermia devices are medical instruments used to raise the temperature of body tissues for therapeutic purposes, often as an adjunct treatment for cancer. By applying controlled heat to specific areas of the body, these devices enhance the efficacy of treatments like chemotherapy and radiation therapy by improving blood flow and increasing the sensitivity of cancer cells to treatment.

The growth of the global hyperthermia devices market is driven by global increase in cancer cases has driven demand for innovative treatment modalities, including hyperthermia devices, which improve the efficacy of traditional cancer therapies like chemotherapy and radiation. According to a 2022 study published by the World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Thus, with patients increasingly seeking less invasive cancer treatments, hyperthermia devices have gained popularity due to their ability to target localized tissues with minimal side effects compared to conventional approaches. In addition, increase in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice. Moreover, rise in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice, thus fostering the market growth. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aging is associated with a decline in immune system efficiency, including reduced surveillance for abnormal or cancerous cells. This has created a significant demand for advanced therapeutic options, including hyperthermia devices. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. The growth of specialized oncology clinics and hospitals worldwide has further facilitated the adoption of advanced cancer treatment modalities, such as hyperthermia therapy, to improve patient outcomes. Despite its benefits, hyperthermia therapy remains underutilized due to limited awareness and training among healthcare providers about its effectiveness and integration into cancer treatment protocols. The cost of hyperthermia treatment, including the devices and associated procedures, can be prohibitive for many patients and healthcare systems, particularly in low- and middle-income regions, further restraining the market growth. On the contrary, Technological innovations, such as improved thermal delivery systems, real-time temperature monitoring, and non-invasive devices, have enhanced the safety, precision, and effectiveness of hyperthermia treatments. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global hyperthermia devices market analysis is segmented into product, application, end user, and region. On the basis of product, the market is categorized into microwave hyperthermia devices and ultrasound hyperthermia devices. Depending on application, it is segregated into breast cancer, prostate cancer, cervical cancer, and others. By end user, it is fragmented into hospitals, cancer treatment centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the ultrasound hyperthermia devices segment is expected to dominate the market from 2024 to 2033.

Depending on application, the prostate cancer segment is anticipated to exhibit the highest growth throughout the forecast period.

By end user, the hospitals segment is projected to grow at a notable pace during the forecast period.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

The major players operating in the global hyperthermia devices Market include Pyrexar Medical, Oncotherm, Celsius42, Andromedic, Pearson, Nanjing Greathope, Shanghai Huayuan, MagForce AG, Nanopores, and Sensius. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product

Microwave Hyperthermia Devices
Ultrasound Hyperthermia Devices

By Application

Breast Cancer
Prostate Cancer
Cervical Cancer
Others

By End User

Hospitals
Cancer treatment centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Pyrexar Medical
Oncotherm
Celsius42
Andromedic
Pearson
Nanjing Greathope
Shanghai Huayuan
MagForce AG
Nanopores
Sensius

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: HYPERTHERMIA DEVICES MARKET, BY PRODUCT

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
4.2. Microwave Hyperthermia Devices
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Ultrasound Hyperthermia Devices
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country

CHAPTER 5: HYPERTHERMIA DEVICES MARKET, BY APPLICATION

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
5.2. Breast Cancer
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Prostate Cancer
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Cervical Cancer
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country

CHAPTER 6: HYPERTHERMIA DEVICES MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Cancer Treatment Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: HYPERTHERMIA DEVICES MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Hyperthermia Devices Market
  - 7.2.6.1. Market Size and Forecast, By Product
  - 7.2.6.2. Market Size and Forecast, By Application
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Hyperthermia Devices Market
  - 7.2.7.1. Market Size and Forecast, By Product
  - 7.2.7.2. Market Size and Forecast, By Application
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Hyperthermia Devices Market
  - 7.2.8.1. Market Size and Forecast, By Product
  - 7.2.8.2. Market Size and Forecast, By Application
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Hyperthermia Devices Market
  - 7.3.6.1. Market Size and Forecast, By Product
  - 7.3.6.2. Market Size and Forecast, By Application
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Hyperthermia Devices Market
  - 7.3.7.1. Market Size and Forecast, By Product
  - 7.3.7.2. Market Size and Forecast, By Application
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Hyperthermia Devices Market
  - 7.3.8.1. Market Size and Forecast, By Product
  - 7.3.8.2. Market Size and Forecast, By Application
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Hyperthermia Devices Market
  - 7.3.9.1. Market Size and Forecast, By Product
  - 7.3.9.2. Market Size and Forecast, By Application
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Hyperthermia Devices Market
  - 7.3.10.1. Market Size and Forecast, By Product
  - 7.3.10.2. Market Size and Forecast, By Application
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Hyperthermia Devices Market
  - 7.3.11.1. Market Size and Forecast, By Product
  - 7.3.11.2. Market Size and Forecast, By Application
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Hyperthermia Devices Market
  - 7.4.6.1. Market Size and Forecast, By Product
  - 7.4.6.2. Market Size and Forecast, By Application
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Hyperthermia Devices Market
  - 7.4.7.1. Market Size and Forecast, By Product
  - 7.4.7.2. Market Size and Forecast, By Application
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Hyperthermia Devices Market
  - 7.4.8.1. Market Size and Forecast, By Product
  - 7.4.8.2. Market Size and Forecast, By Application
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Hyperthermia Devices Market
  - 7.4.9.1. Market Size and Forecast, By Product
  - 7.4.9.2. Market Size and Forecast, By Application
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Hyperthermia Devices Market
  - 7.4.10.1. Market Size and Forecast, By Product
  - 7.4.10.2. Market Size and Forecast, By Application
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Hyperthermia Devices Market
  - 7.4.11.1. Market Size and Forecast, By Product
  - 7.4.11.2. Market Size and Forecast, By Application
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Hyperthermia Devices Market
  - 7.5.6.1. Market Size and Forecast, By Product
  - 7.5.6.2. Market Size and Forecast, By Application
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Hyperthermia Devices Market
  - 7.5.7.1. Market Size and Forecast, By Product
  - 7.5.7.2. Market Size and Forecast, By Application
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Hyperthermia Devices Market
  - 7.5.8.1. Market Size and Forecast, By Product
  - 7.5.8.2. Market Size and Forecast, By Application
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Hyperthermia Devices Market
  - 7.5.9.1. Market Size and Forecast, By Product
  - 7.5.9.2. Market Size and Forecast, By Application
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Pyrexar Medical
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Oncotherm
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Celsius42
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. Andromedic
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Pearson
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Nanjing Greathope
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. Shanghai Huayuan
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. MagForce AG
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Nanopores
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Sensius
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 4,425

￦ 6,402,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

US $ 7,412

￦ 10,724,000

※ 부가세 별도